Monopar Therapeutics Inc. (MNPR) Balance Sheet
As of 2026-06-30 (10-Q), Monopar Therapeutics Inc. (MNPR) reported total assets of $135.0M, total liabilities of $4.1M and shareholders' equity of $130.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $52.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MNPRMonopar Therapeutics Inc.Follow MNPR — free
—
Price chart with a free account
- Market cap
- 474.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.1 | 9.0 | 6.9 | 13.2 | 16.7 | 20.3 | 8.2 | 7.3 | 45.8 | 61.8 | 52.8 | |
| Short-term investments | — | — | — | — | — | — | 12.2 | 6.5 | 45.5 | 60.9 | 52.6 | |
| Current assets | 2.1 | 9.1 | 7.3 | 13.2 | 16.8 | 20.5 | 13.2 | 7.3 | 60.3 | 140.5 | 134.8 | |
| Total assets | 2.9 | 9.9 | 7.3 | 13.4 | 16.9 | 20.5 | 13.2 | 7.3 | 60.3 | 140.7 | 135.0 | |
| Current liabilities | 0.1 | 0.3 | 0.4 | 0.7 | 1.2 | 1.6 | 3.1 | 1.8 | 5.3 | 2.7 | 4.0 | |
| Total liabilities | 0.1 | 0.3 | 0.4 | 0.7 | 1.2 | 1.6 | 3.1 | 1.8 | 5.3 | 2.9 | 4.1 | |
| Shareholders' equity | 2.8 | 9.6 | 6.9 | 12.6 | 15.7 | 18.9 | 10.1 | 5.6 | 55.0 | 137.8 | 130.9 |
USD millions · SEC XBRL
Monopar Therapeutics Inc. — questions
- How much cash does Monopar Therapeutics Inc. have?
- $52.8M in cash and cash equivalents as of 2026-06-30.
- What are Monopar Therapeutics Inc.'s total assets?
- $135.0M as of 2026-06-30.
- What is Monopar Therapeutics Inc.'s shareholders' equity?
- $130.9M as of 2026-06-30.
Every figure on this page comes from Monopar Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.